Successes and Challenges of NK ImmunotherapyBenjamin Bonavida, Anahid Jewett · First published 2021Open the Tome
New Combination Approaches to Enhance Rituximab-Based Lymphoma TherapiesBenjamin Bonavida · First published 2020Open the Tome
Overcoming Cancers Resistant to HER-2 AntibodiesBenjamin Bonavida · First published 2020Open the Tome
YY1 Is Pivotal in the Control of the Pathogenesis and Drug Resistance of CancerBenjamin Bonavida · First published 2020Open the Tome
Therapeutic Application of Nitric Oxide in Cancer and Inflammatory DisordersLucia Morbidelli, Benjamin Bonavida · First published 2019Open the Tome
Nitric Oxide (Donor/Induced) in ChemosensitizationBenjamin Bonavida · First published 2017Open the Tome
Resistance of Cancer Cells to CTL-Mediated ImmunotherapyBenjamin Bonavida, Salem Chouaib · First published 2015Open the Tome
Molecular Mechanisms of Tumor Cell Resistance to ChemotherapyBenjamin Bonavida · First published 2013Open the Tome
Molecular Mechanisms Of Tumor Cell Resistance To Chemotherapy Targeted Therapies To Reverse ResistanceBenjamin Bonavida · First published 2013Open the Tome
Resistance to Immunotherapeutic Antibodies in CancerBenjamin Bonavida · First published 2013Open the Tome
Resistance to Immunotherapeutic Antibodies in Cancer Resistance to Targeted AntiCancer TherapeuticsBenjamin Bonavida · First published 2013Open the Tome
Sensitization of cancer cells for chemo/immuno/radio-therapyBenjamin Bonavida · First published 2008Open the Tome
Rituximab-mediated molecular signaling and interactions with chemotherapeutic drugsBenjamin Bonavida · First published 2007Open the Tome
Chemo-immunosensitization of resistant tumor cells to cell death by apoptosis, 2006Benjamin Bonavida · First published 2006Open the Tome
Tumor Necrosis Factor: Structure, Mechanism of Action, Role in Disease and TherapyBenjamin Bonavida · First published 1990Open the Tome
Tumor Necrosis Factor/Cachetin and Related CytokinesBenjamin Bonavida · First published 1988Open the Tome
